Medlumics — No stage disclosed · €990K partial: only one investor's ticket was disclosed

CDTI Innovación, through its Innvierte programme, announced a co-investment agreement with Asabys Partners (via Sabadell Asabys Health Innovation Investments and Asabys Top Up Fund) in MedLumics, developer of the AblaView optically-guided cardiac ablation catheter for atrial fibrillation. The total round size was not disclosed; CDTI's committed contribution was €990,000.